Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

Por um escritor misterioso

Descrição

Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Table 4 from Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Management of Hypertension in Pregnancy
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Clinical Evaluation of Pinggan Yiqi Yangshen Recipe Combined with Labetalol Hydrochloride and Magnesium Sulfate in the Treatment of PIH
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson's Disease: What We Know and Where to Go
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Labetalol (AH5158), α1/β-adrenergic Receptors Antagonist
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
ABC Cardiol
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Best Practices for Managing Postpartum Hypertension
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review. - Abstract - Europe PMC
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
PDF) Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Maternal Medicine (Section 4) - The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
de por adulto (o preço varia de acordo com o tamanho do grupo)